- KALA BIO Inc at HC Wainwright Ophthalmology Virtual Conference - Pre Recorded TranscriptAug 16, 2023
- Kala Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q2 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2022$16.4 (-5.75%)Earnings
- Q1 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 16, 2022$37.08 (+8.47%)Earnings
- Q4 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 29, 2022$75 (-14.29%)Earnings
- Q3 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 15, 2021$105 (+1.45%)Earnings
- Q2 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$159 (-5.07%)Earnings
- Kala Pharmaceuticals Inc at BofA Securities 2021 Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$297.5 (-7.75%)Earnings
- Q4 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021$386.75 (-13.38%)Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$363 (+0.14%)Earnings
- Kala Pharmaceuticals, Inc. - Special Call TranscriptOct 27, 2020
- Kala Pharmaceuticals, Inc. - Special Call TranscriptSep 17, 2020
- Q2 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020$458.5Earnings
- Kala Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$592.5 (+1.98%)Earnings
- Kala Pharmaceuticals Inc STRIDE 3 Data Conference Call TranscriptMar 09, 2020
- Q4 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 12, 2020$313.5 (-1.95%)Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019$185.5 (-3.39%)Earnings
- Q2 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019$219 (-13.27%)Earnings
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2019$347 (-2.25%)Earnings
- Q4 2018 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 11, 2019Earnings
Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Chris Neyor from the U.S. pharma team at JPMorgan, and I'm glad to introduce Kala Pharmaceuticals and CEO, Mark Iwicki, here with us today. Kala has 2 exciting products in the dry eye space on its AMPPLIFY platform or rather in the ophthalmology space. That's INVELTYS for postsurgical pain and inflammation launched in 2019 and EYSUVIS for acute dry eye with the pivotal Phase III reading out in 1Q 2020.
We're going to have a presentation from Mark, and then we'll be following up with a breakout session in Elizabethan C next door.
With that, I'll hand it over to Mark.
Thanks, Chris. Morning, everyone. Thanks for taking the time to be with us this morning. And as Chris said, I'm Mark Iwicki. I'm the CEO of the company. I've been at Kala for almost 5 years. We'll make some forward-looking statements this morning. So here's our appropriate disclaimer and notice about that.
We have a very
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)